Abstract
In this article, scores used to assess the efficacy of treatments in the field of pediatric inflammatory rheumatisms are reviewed. In juvenile arthritis, assessment of treatment efficacy usually refers to the American College of Rheumatology (ACR) pediatric score (or Pediatric Rheumatology International Trial Organisation [PRINTO]), which has similarities with the ACR criteria used in adult rheumatoid arthritis. Other validated questionnaires include the child-HAQ. Discussions are ongoing regarding remission criteria for children. These scores are reviewed here.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
